Table 1.
Characteristics of lung cancer patients which are involved in determining Sp1 and Nm23 expression by.
| Characteristics | Sp1 high | Sp1 low | p-value |
|---|---|---|---|
| Patients (n) | 135 (76.3%) | 42 (23.7%) | |
| Nm23 high | 105 (80.2%) | 26 (19.8%) | 0.0462*a |
| Nm23 low | 30 (65.2%) | 16 (34.8%) | |
| Gender Male | 78 (75%) | 26 (25%) | 0.7208a |
| Female | 57 (78.1%) | 16 (21.9%) | |
| Age (mean ± s.e.m) | 65.3 ± 0.96 | 65.0 ± 1.6 | 0.8746b |
| ADC 1 | 114 (81.4%) | 26 (28.6%) | 0.0131*a |
| SCC 2 | 17 (58.6%) | 12 (41.4%) | |
| LCC 3 | 3 (60%) | 2 (40%) | |
| Stages I & II | 105 (94.6%) | 6 (5.4%) | p < 0.0001***a |
| III & IV | 30 (45.5%) | 36 (54.5%) | |
| Recurrence | 8 (40%) | 12 (60%) |
Abbreviation:1adenocarcinoma;2squamous cell carcinoma;3large cell carcinoma.
aFisher’s extract test, bStudnet’s t test.